Literature DB >> 6341477

Transfer of trimethoprim resistance from fecal Escherichia coli isolated during a prophylaxis study in Mexico.

B E Murray, E R Rensimer.   

Abstract

Forty-one of 100 trimethoprim-resistant fecal isolates of Escherichia coli isolated during a diarrhea prophylaxis study transferred trimethoprim resistance to an E. coli K12 derivative at frequencies ranging from 1 x 10(-7) to 2 x 10(-2). Analysis of these transconjugants, after attempting to select those that had received only one plasmid, revealed that 34 (83%) were resistant to trimethoprim plus only one or two of seven other antimicrobial agents tested, most often ampicillin and/or streptomycin. In contrast, 91% of the donor strains were resistant to four or more antimicrobial agents. Plasmid analysis demonstrated that a 35-megadalton plasmid was present in 35 transconjugants and was usually associated with resistance to trimethoprim, streptomycin, and ampicillin; 19 transconjugants had only a 35-megadalton plasmid and were resistant to only these three antimicrobial agents, raising the possibility that a common plasmid was present in many strains. Although resistance to multiple antimicrobial agents could be transferred to the K12 recipient, resistance to more than three agents was seldom mediated by a single plasmid. The high degree of transferability of trimethoprim resistance from these fecal isolates of E. coli emphasizes the potential for the dissemination of genes carrying trimethoprim resistance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341477     DOI: 10.1093/infdis/147.4.724

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

Review 1.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

2.  Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas.

Authors:  R R Reves; M Fong; L K Pickering; A Bartlett; M Alvarez; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

3.  Changes in Escherichia coli resistance to co-trimoxazole in tuberculosis patients and in relation to co-trimoxazole prophylaxis in Thyolo, Malawi.

Authors:  R Zachariah; A D Harries; M P Spielmann; V Arendt; D Nchingula; R Mwenda; O Courtielle; P Kirpach; B Mwale; Fml Salaniponi
Journal:  Malawi Med J       Date:  2002-09       Impact factor: 0.875

4.  Identification by DNA sequence analysis of a new plasmid-encoded trimethoprim resistance gene in fecal Escherichia coli isolates from children in day-care centers.

Authors:  K V Singh; R R Reves; L K Pickering; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

5.  EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FAECAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOS.

Authors:  C C Egwuatu; A A Iwuafor; T O Egwuatu; C N Akujobi; A U Nnachi; I N Aghanya; F T Ogunsola; O O Oduyebo
Journal:  Afr J Infect Dis       Date:  2016-05-01

6.  EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FEACAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOS.

Authors:  C C Egwuatu; F T Ogunsola; A A Iwuafor; C N Akujobi; T O Egwuatu; A U Nnachi; O O Oduyebo
Journal:  Afr J Infect Dis       Date:  2016-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.